NOV 25, 2019 11:33 AM PST

Using AI to determine which patients are best suited for immunotherapy

A new study published in the journal Cancer Immunology Research suggests that we can use artificial intelligence to help determine which people with lung cancer would benefit the most from immunotherapy. The AI model was developed by researchers at Case Western Reserve University in collaboration with other scientists.

Lung cancer is a frightening diagnosis to receive because early detection is so limited that patients are often diagnosed when the disease has already reached advanced stages. The National Cancer Institute estimates that lung and bronchus cancer accounts for 12.9% of all new cancer diagnoses in the US, making it the second most widespread type of cancer nationally. In developing a treatment plan after diagnosis, immunotherapy is one of the treatment options that patients and their doctors may consider – however, immunotherapy is not effective for all patients and the risk isn’t always worth the outcome. Study co-author Anant Madabhushi explains:

"Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive — about $200,000 per patient, per year. That's part of the financial toxicity that comes along with cancer and results in about 42% of all newly diagnosed cancer patients losing their life savings within a year of diagnosis," he adds.

So, figuring out if immunotherapy will be of actual benefit to a patient before undergoing the treatment is of utmost priority. To work on this goal, the research team analyzed data from CT scans of 50 people with lung cancer in order to determine patterns of textural and size change in tumors following two or three immunotherapy cycles. They were able to conclude that patients with lung cancer tumors that demonstrate the most noticeable changes in texture are best suited to immunotherapy response and subsequence higher patient survival.

Lung cancer is often detected once it has already reached advanced stages, making choosing the right treatment of utmost urgency. Photo: Pixabay

"This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors. We are dealing with a fundamental biological principle," comments co-author Prateek Prasanna. The researchers hope to continue advancing their AI model in order to increase knowledge on immunotherapy effectiveness for individuals.

Sources: Cancer Immunology Research, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
FEB 12, 2020
Cancer
FEB 12, 2020
Can we eradicate cervical cancer within a century?
Two studies recently published in The Lancet present evidence that the eradication of cervical cancer could be possible within the next century. The World ...
MAR 15, 2020
Cell & Molecular Biology
MAR 15, 2020
Immune Cells Can Attack Tumors Remotely
The body's immune system is able to identify the cancerous cells of a tumor and launch an attack against them....
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood....
MAR 29, 2020
Cancer
MAR 29, 2020
Improving ependymoma diagnostics
Have you ever heard of ependymoma? This rare form of brain cancer most commonly occurs in young children when tumors form from ependymal cells in the brain...
Loading Comments...